CoreWeave to acquire Core Scientific in $9 billion all-stock deal

AI hyperscaler CoreWeave is acquiring data center provider Core Scientific in an all-stock deal valued at approximately $9 billion, a strategic move to internalize critical infrastructure and strengthen CoreWeave's position in the AI market. This acquisition, expected to close in Q4 2025, will grant CoreWeave ownership of 1.3 gigawatts of Core Scientific's data center capacity, eliminating $10 billion in future lease obligations and enhancing operational efficiency. Despite the clear strategic rationale and a 66% premium for Core Scientific shareholders relative to pre-deal-talks pricing, CoreWeave's stock declined 4% and Core Scientific's fell 20% on the announcement.

Analysis

CoreWeave's acquisition of Core Scientific in a ~$9 billion all-stock transaction represents a significant vertical integration move within the competitive artificial intelligence sector. By bringing Core Scientific's data center infrastructure in-house, CoreWeave secures ownership of 1.3 gigawatts of power capacity, with an additional gigawatt available for expansion, thereby de-risking its long-term growth and eliminating an estimated $10 billion in future lease obligations. Despite the clear strategic rationale, the market reaction was negative, with CoreWeave's stock falling 4% and Core Scientific's plummeting 20% on the announcement, contrasting with a rally in late June when deal talks were first reported. This price action suggests a "sell the news" event. For Core Scientific shareholders, the deal offers a 66% premium to the pre-rumor stock price, exchanging their shares at an implied value of $20.40 for 0.1235 CoreWeave shares each, though they will ultimately own less than 10% of the combined company. The transaction, contingent on regulatory and shareholder approval, is not expected to close until the fourth quarter of 2025, introducing a lengthy period of uncertainty.

Key Decisions for Investors

• Investors should recognize the sharp stock declines in both companies as a probable 'sell the news' event following a rally on deal rumors, and evaluate if current prices offer a compelling entry point based on the long-term strategic value of the combined entity.
• Core Scientific shareholders must weigh the offered 66% premium against the risks of an all-stock transaction and a long closing timeline, as their future returns will be tied directly to CoreWeave's performance and integration success post-merger.
• For investors bullish on AI infrastructure, this acquisition strengthens CoreWeave's competitive position, but it is prudent to monitor execution risks, integration synergies, and regulatory hurdles ahead of the expected Q4 2025 closing.